AGIOS PHARMACEUTICALS

Lobbying for AGIOS PHARMACEUTICALS · Pharmacy, Medicare/Medicaid, Health Issues

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 17, 2025

Expenses

$10,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 3

Health Issues

Sickle Cell policy Biotech innovation

Medical/Disease Research/Clinical Labs

Biotech Innovation

Medicare/Medicaid

Medicaid Reform

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.